A Single-Center Pilot Study to Assess Macular Function
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
20 Years to 90 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Three groups of subjects will be enrolled:
Normal healthy subjects aged 20-29 years
Normal healthy subjects aged 60-90 years
Subjects with early dry AMD
Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
Subjects with early non-exudative age-related macular degeneration (AMD cohort)
Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study